News Features ‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings Michael O'Riordan September 17, 2025
News Features AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts Michael O'Riordan February 19, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts Michael O'Riordan October 21, 2024
News Features ‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special L.A. McKeown September 25, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Features Chaos and Questions: New Public-Access Policies Put Journals in Flux Michael O'Riordan August 14, 2023
News Features As US Abortion Access Grows Patchier, Cardiologist Concerns Mount Todd Neale May 15, 2023
News Features THT 2023 The Promise of AI for Improving Health Equity in Heart Failure Todd Neale April 04, 2023
News Features Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks Caitlin E. Cox February 03, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Features Bullying in Cardiology: Has More Diversity Led to Backlash? Caitlin E. Cox December 14, 2022
News Features Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI? L.A. McKeown December 02, 2022
News Features From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine L.A. McKeown October 18, 2022
News Features Aortic Valve Replacement: What’s on the Wish List for Future Devices? Shelley Wood March 14, 2022
News Features Bloodlines: How Far Should Cardiologists Go in Treating Family? Todd Neale March 10, 2022
News Features Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’ Todd Neale February 14, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022